Best Growth Stock Picks
Immune Design and Westlake Chemical Partners are a few noticeable companies with a strong future outlook. The market’s optimistic sentiment towards these stocks indicates a level of confidence in the future outlook of their businesses. I would suggest taking a look at my list of companies that compare favourably in all criteria, and consider whether they would add value to your current portfolio.
Immune Design Corp. (NASDAQ:IMDZ)
Immune Design Corp., a clinical-stage immunotherapy company, engages in the research and development of in vivo treatments for cancer. Founded in 2008, and currently headed by CEO Carlos Paya, the company now has 51 employees and with the company’s market capitalisation at USD $156.19M, we can put it in the small-cap group.
IMDZ’s projected future profit growth is a robust 26.30%, with an underlying triple-digit growth from its revenues expected over the upcoming years. It appears that IMDZ’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. IMDZ ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Thinking of investing in IMDZ? Take a look at its other fundamentals here.
Westlake Chemical Partners LP (NYSE:WLKP)
Westlake Chemical Partners LP operates, acquires, and develops ethylene production facilities and related assets in the United States. Westlake Chemical Partners was formed in 2014 and with the stock’s market cap sitting at USD $754.29M, it comes under the small-cap group.
Extreme optimism for WLKP, as market analysts projected an outstanding earnings growth rate of 40.88% for the stock, supported by a double-digit sales growth of 17.90%. It appears that WLKP’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 31.08%. WLKP ticks the boxes for robust growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Should you add WLKP to your portfolio? Have a browse through its key fundamentals here.
BP Midstream Partners LP (NYSE:BPMP)
BP Midstream Partners LP owns, acquires, operates, and develops pipelines and other midstream assets. The company was established in 2017 and with the company’s market capitalisation at USD $2.10B, we can put it in the mid-cap stocks category.
Driven by the positive double-digit sales growth of 36.47% over the next few years, BPMP is expected to deliver an excellent earnings growth of 34.95%. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 88.91%. BPMP’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Thinking of investing in BPMP? Take a look at its other fundamentals here.
For more financially robust companies with high growth potential to enhance your portfolio, use our free platform to explore our interactive list of these stocks.
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned.
